378 related articles for article (PubMed ID: 25734337)
1. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy B; Penninger JM; Popper H; Casanova E
Nat Commun; 2015 Mar; 6():6285. PubMed ID: 25734337
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
[TBL] [Abstract][Full Text] [Related]
3. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
[TBL] [Abstract][Full Text] [Related]
4. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
5. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer: Driver-mutation-dependent stratification: learning from STAT3.
Errico A
Nat Rev Clin Oncol; 2015 May; 12(5):251. PubMed ID: 25781574
[No Abstract] [Full Text] [Related]
7. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
[TBL] [Abstract][Full Text] [Related]
8. Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Deng S; Ramos-Castaneda M; Velasco WV; Clowers MJ; Gutierrez BA; Noble O; Dong Y; Zarghooni M; Alvarado L; Caetano MS; Yang S; Ostrin EJ; Behrens C; Wistuba II; Stabile LP; Kadara H; Watowich SS; Moghaddam SJ
Carcinogenesis; 2020 Nov; 41(11):1529-1542. PubMed ID: 32603404
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of STAT3 in the initiation and growth of lung cancer.
Zhou J; Qu Z; Yan S; Sun F; Whitsett JA; Shapiro SD; Xiao G
Oncogene; 2015 Jul; 34(29):3804-3814. PubMed ID: 25284582
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.
Baumgart S; Chen NM; Siveke JT; König A; Zhang JS; Singh SK; Wolf E; Bartkuhn M; Esposito I; Heßmann E; Reinecke J; Nikorowitsch J; Brunner M; Singh G; Fernandez-Zapico ME; Smyrk T; Bamlet WR; Eilers M; Neesse A; Gress TM; Billadeau DD; Tuveson D; Urrutia R; Ellenrieder V
Cancer Discov; 2014 Jun; 4(6):688-701. PubMed ID: 24694735
[TBL] [Abstract][Full Text] [Related]
11. IL22 Promotes
Khosravi N; Caetano MS; Cumpian AM; Unver N; De la Garza Ramos C; Noble O; Daliri S; Hernandez BJ; Gutierrez BA; Evans SE; Hanash S; Alekseev AM; Yang Y; Chang SH; Nurieva R; Kadara H; Chen J; Ostrin EJ; Moghaddam SJ
Cancer Immunol Res; 2018 Jul; 6(7):788-797. PubMed ID: 29764837
[TBL] [Abstract][Full Text] [Related]
12. Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor.
Zarredar H; Pashapour S; Farajnia S; Ansarin K; Baradaran B; Ahmadzadeh V; Safari F
J Cell Biochem; 2019 Jun; 120(6):10670-10677. PubMed ID: 30656741
[TBL] [Abstract][Full Text] [Related]
13. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
[TBL] [Abstract][Full Text] [Related]
14. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.
Okayama H; Saito M; Oue N; Weiss JM; Stauffer J; Takenoshita S; Wiltrout RH; Hussain SP; Harris CC
Int J Cancer; 2013 Jan; 132(1):9-18. PubMed ID: 22618808
[TBL] [Abstract][Full Text] [Related]
15. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
16. STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis.
D'Amico S; Shi J; Martin BL; Crawford HC; Petrenko O; Reich NC
Genes Dev; 2018 Sep; 32(17-18):1175-1187. PubMed ID: 30135074
[TBL] [Abstract][Full Text] [Related]
17. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma.
Meylan E; Dooley AL; Feldser DM; Shen L; Turk E; Ouyang C; Jacks T
Nature; 2009 Nov; 462(7269):104-7. PubMed ID: 19847165
[TBL] [Abstract][Full Text] [Related]
18. Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer.
Feng J; Jiang W; Liu Y; Huang W; Hu K; Li K; Chen J; Ma C; Sun Z; Pang X
Biochem Pharmacol; 2020 Jul; 177():113960. PubMed ID: 32298693
[TBL] [Abstract][Full Text] [Related]
19. IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis.
Brooks GD; McLeod L; Alhayyani S; Miller A; Russell PA; Ferlin W; Rose-John S; Ruwanpura S; Jenkins BJ
Cancer Res; 2016 Feb; 76(4):866-76. PubMed ID: 26744530
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]